newsfilter
← Latest News
PR Newswire·

Immunic to Host Virtual Progressive Multiple Sclerosis R&D Day on November 5, 2026

NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Immunic, Inc. (NASDAQ:IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced that it will host a